US5384253A
(en)
*
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
JPH07213285A
(ja)
*
|
1994-01-31 |
1995-08-15 |
Norin Suisansyo Nogyo Kenkyu Center Shocho |
植物細胞への遺伝子導入法
|
FR2715847B1
(fr)
*
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
US5962427A
(en)
|
1994-02-18 |
1999-10-05 |
The Regent Of The University Of Michigan |
In vivo gene transfer methods for wound healing
|
US5763416A
(en)
|
1994-02-18 |
1998-06-09 |
The Regent Of The University Of Michigan |
Gene transfer into bone cells and tissues
|
US5942496A
(en)
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
US6074840A
(en)
|
1994-02-18 |
2000-06-13 |
The Regents Of The University Of Michigan |
Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
|
US20020193338A1
(en)
*
|
1994-02-18 |
2002-12-19 |
Goldstein Steven A. |
In vivo gene transfer methods for wound healing
|
US6551618B2
(en)
*
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
DE4418965A1
(de)
*
|
1994-05-31 |
1995-12-07 |
Boehringer Ingelheim Int |
Verfahren zum Einbringen von Nukleinsäure in höhere eukaryotische Zellen
|
AU737314B2
(en)
*
|
1994-07-13 |
2001-08-16 |
Aventis Pharma S.A. |
Nucleic acid containing composition, preparation and uses of same
|
FR2722506B1
(fr)
*
|
1994-07-13 |
1996-08-14 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucleiques, preparation et utilisations
|
AUPM747694A0
(en)
*
|
1994-08-16 |
1994-09-08 |
Commonwealth Scientific And Industrial Research Organisation |
Delivery of nucleic acids and peptides
|
DE69527206T2
(de)
*
|
1994-09-30 |
2003-02-27 |
Inex Pharmaceuticals Corp |
Mittel zum einbringen polyanionischer materialien in zellen
|
US5753613A
(en)
*
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
US20030069173A1
(en)
|
1998-03-16 |
2003-04-10 |
Life Technologies, Inc. |
Peptide-enhanced transfections
|
US5908777A
(en)
*
|
1995-06-23 |
1999-06-01 |
University Of Pittsburgh |
Lipidic vector for nucleic acid delivery
|
US5859327A
(en)
|
1995-08-22 |
1999-01-12 |
Genetronics, Inc. |
Electroporation-mediated molecular transfer in intact plants
|
US6120794A
(en)
|
1995-09-26 |
2000-09-19 |
University Of Pittsburgh |
Emulsion and micellar formulations for the delivery of biologically active substances to cells
|
FR2739292B1
(fr)
*
|
1995-09-28 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
|
AU7342296A
(en)
*
|
1995-10-25 |
1997-05-15 |
Octoplus Bv |
Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
|
US5980935A
(en)
*
|
1996-05-15 |
1999-11-09 |
Kirpotin; Dmitri |
Cationic lipids and methods of use therefor
|
FR2751222B1
(fr)
*
|
1996-07-16 |
1998-10-09 |
Capsulis |
Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
|
JP4656675B2
(ja)
*
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
EP2113247A3
(de)
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
Hochwirksame Verkapselung von Nukleinsäuren in Lipidvesikeln
|
DE69840361D1
(de)
|
1997-07-30 |
2009-01-29 |
Univ Emory |
Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
CA2335638A1
(en)
*
|
1998-06-19 |
1999-12-23 |
Ronald K. Scheule |
Cationic amphiphile micellar complexes
|
DE60036861T2
(de)
*
|
1999-03-02 |
2008-07-24 |
Transave, Inc. |
Verkapselung biologisch aktiver komplexe in liposomen
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
US9486429B2
(en)
*
|
1999-06-01 |
2016-11-08 |
Vanderbilt University |
Therapeutic methods employing nitric oxide precursors
|
US20010048940A1
(en)
*
|
1999-06-18 |
2001-12-06 |
Jennifer D. Tousignant |
Cationic amphiphile micellar complexes
|
EP1194449B1
(de)
*
|
1999-06-28 |
2010-09-22 |
Oklahoma Medical Research Foundation |
Inhibitoren des memapsin 2 und ihre verwendung
|
CA2390716A1
(en)
*
|
1999-09-24 |
2001-04-05 |
Alan D. King |
Process for enhancing electric field-mediated delivery of biological materials into cells
|
AU2002246758A1
(en)
*
|
2000-12-29 |
2002-07-16 |
Vanderbilt University |
Epididymal lipocalin gene and uses thereof
|
AU2002256398A2
(en)
*
|
2001-04-30 |
2002-11-11 |
Targeted Genetics Corporation |
Lipid-comprising drug delivery complexes and methods for their production
|
WO2003038103A1
(en)
*
|
2001-10-29 |
2003-05-08 |
Atso Raasmaja |
Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
|
AU2002340662B2
(en)
*
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20050069918A1
(en)
|
2003-05-29 |
2005-03-31 |
Francois Claret |
JAB1 as a prognostic marker and a therapeutic target for human cancer
|
WO2007001324A2
(en)
|
2004-07-23 |
2007-01-04 |
The University Of North Carolina At Chapel Hill |
Methods and materials for determining pain sensitivity and predicting and treating related disorders
|
AU2006279896A1
(en)
*
|
2005-08-10 |
2007-02-22 |
Oklahoma Medical Research Foundation |
Truncated memapsin 2 for use for treating Alzheimer's disease
|
EP2395012B8
(de)
|
2005-11-02 |
2018-06-06 |
Arbutus Biopharma Corporation |
Modifizierte siRNA-Moleküle und Verwendungen davon
|
US8097712B2
(en)
|
2007-11-07 |
2012-01-17 |
Beelogics Inc. |
Compositions for conferring tolerance to viral disease in social insects, and the use thereof
|
CA2708153C
(en)
|
2007-12-04 |
2017-09-26 |
Alnylam Pharmaceuticals, Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
EP2238251B1
(de)
|
2007-12-27 |
2015-02-11 |
Protiva Biotherapeutics Inc. |
Silencing der polo-like-kinase-expression unter verwendung von interferenz-rna
|
EP3100718B1
(de)
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Verbesserte zusammensetzungen und verfahren zur freisetzung von nukleinsäuren
|
JP5623916B2
(ja)
*
|
2008-01-31 |
2014-11-12 |
バンダービルト・ユニバーシティVanderbilt University |
動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
|
TR201903753T4
(tr)
*
|
2008-01-31 |
2019-03-21 |
Univ Vanderbilt |
Akciğer rahatsızlıkları için terapötik tedavi.
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
PL2279254T3
(pl)
|
2008-04-15 |
2017-11-30 |
Protiva Biotherapeutics Inc. |
Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
|
US9139554B2
(en)
|
2008-10-09 |
2015-09-22 |
Tekmira Pharmaceuticals Corporation |
Amino lipids and methods for the delivery of nucleic acids
|
EP4241767A3
(de)
|
2008-11-10 |
2023-11-01 |
Arbutus Biopharma Corporation |
Neuartige lipide und zusammensetzungen zur verabreichung von therapeutika
|
EP3243504A1
(de)
|
2009-01-29 |
2017-11-15 |
Arbutus Biopharma Corporation |
Verbesserte lipidformulierung
|
NZ594995A
(en)
|
2009-03-12 |
2013-06-28 |
Alnylam Pharmaceuticals Inc |
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES
|
BRPI1009271A8
(pt)
|
2009-03-19 |
2016-02-10 |
Merck Sharp & Dohme |
Molécula de ácido nucleico interferente curto de filamento duplo, composição farmacêutica, e, método para tratar um indivíduo humano que sofre de uma condição que é mediada pela ação, ou pela perda de ação, de bach1
|
US20120016011A1
(en)
|
2009-03-19 |
2012-01-19 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
WO2010107957A2
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
JP2012520686A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いたシグナル伝達性転写因子6(STAT6)遺伝子発現のRNA干渉媒介性阻害
|
JP2012521760A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いたアポトーシスシグナル調節キナーゼ1(ASK1)遺伝子発現のRNA干渉媒介性阻害
|
CN102439152A
(zh)
|
2009-03-27 |
2012-05-02 |
默沙东公司 |
使用短干扰核酸(siNA)的RNA干扰介导的细胞间粘附分子1(ICAM-1)基因表达的抑制
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
EP2411520A2
(de)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
Rna-interferenz-vermittelte hemmung der genexpression von tslp (thymic stromal lymphopoietin) unter verwendung von sina (short interfering nucleic acid)
|
EP2411018A2
(de)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
Rna-interferenz-vermittelte hemmung der nervenwachstumsfaktor-betaketten (ngf9-gen-expression mittels sina (short interfering nucleic acid)
|
NZ621981A
(en)
|
2009-05-05 |
2015-09-25 |
Tekmira Pharmaceuticals Corp |
Lipid compositions
|
CA3045126A1
(en)
|
2009-05-05 |
2010-11-11 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
HUE056773T2
(hu)
|
2009-06-10 |
2022-03-28 |
Arbutus Biopharma Corp |
Továbbfejlesztett lipid készítmény
|
EP2449114B9
(de)
|
2009-07-01 |
2017-04-19 |
Protiva Biotherapeutics Inc. |
Neue lipidformulierungen zur abgabe von therapiemitteln in feste tumore
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
AP3574A
(en)
|
2009-08-14 |
2016-02-08 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
CA2775092A1
(en)
|
2009-09-23 |
2011-03-31 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
WO2011056682A1
(en)
|
2009-10-27 |
2011-05-12 |
The University Of British Columbia |
Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
|
CA2783372C
(en)
|
2009-12-07 |
2019-07-16 |
Muthiah Manoharan |
Compositions for nucleic acid delivery
|
ES2749426T3
(es)
|
2009-12-18 |
2020-03-20 |
Univ British Columbia |
Métodos y composiciones para administración de ácidos nucleicos
|
CA2790211C
(en)
|
2010-03-08 |
2020-06-09 |
Monsanto Technology Llc |
Methods and compositions for delivering polynucleotides into plants
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
CA2799091A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
IL300109A
(en)
|
2010-06-03 |
2023-03-01 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the transfer of active substances
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
JP6043285B2
(ja)
|
2010-08-02 |
2016-12-14 |
サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. |
低分子干渉核酸(siNA)を用いたカテニン(カドヘリン結合型タンパク質)β1(CTNNB1)遺伝子発現のRNA干渉媒介性阻害
|
HUE044815T2
(hu)
|
2010-08-17 |
2019-11-28 |
Sirna Therapeutics Inc |
Hepatitisz B vírus (HBV) génexpressziójának RNS-interferencia közvetített gátlása, rövid interferáló nukleinsav (SINS) alkalmazásával
|
US9233997B2
(en)
|
2010-08-26 |
2016-01-12 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
|
US9260471B2
(en)
|
2010-10-29 |
2016-02-16 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
|
WO2012099755A1
(en)
|
2011-01-11 |
2012-07-26 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
BR112014005975A8
(pt)
|
2011-09-13 |
2017-09-12 |
Monsanto Technology Llc |
Método de controle de planta, método de redução de expressão de um gene pds em uma planta, cassete de expressão microbiana, método de fazer um polinucleotídeo, método de identificação de polinucleotídeos, e composições para controle de erva daninha
|
WO2013049328A1
(en)
|
2011-09-27 |
2013-04-04 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
EP2780456A1
(de)
|
2011-11-17 |
2014-09-24 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Therapeutische rna schalter-zusammensetzungen und anwendungsverfahren dafür
|
EP2606897A1
(de)
|
2011-12-22 |
2013-06-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Verfahren und Zusammensetzungen für die Behandlung von Krankheiten, die von eingehüllten Viren verursacht werden
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
BR112014020824B1
(pt)
|
2012-02-24 |
2022-10-04 |
Protiva Biotherapeutics Inc |
Lipídeo, partícula de lipídeo e composição farmacêutica
|
EP3919620A1
(de)
|
2012-05-02 |
2021-12-08 |
Sirna Therapeutics, Inc. |
Zusammensetzungen mit kurzer interferierender nukleinsäure (sina)
|
AU2013264742B2
(en)
|
2012-05-24 |
2018-10-04 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
EP2882849A4
(de)
|
2012-08-10 |
2016-01-13 |
Univ Columbia |
Injizierbare braune fettmikrogewebe zur behandlung und vorbeugung von adipositas und diabetes
|
BR112015012840A2
(pt)
|
2012-12-06 |
2017-07-11 |
Merck Sharp & Dohme |
composto, composição, e, uso de um composto ou um sal, solvato, éster ou pró-droga farmaceuticamente aceitável do mesmo
|
WO2014106837A2
(en)
|
2013-01-01 |
2014-07-10 |
A. B. Seeds Ltd. |
ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
CA2905027A1
(en)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
AR095233A1
(es)
|
2013-03-13 |
2015-09-30 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3030663B1
(de)
|
2013-07-19 |
2019-09-04 |
Monsanto Technology LLC |
Zusammensetzungen und verfahren zur bekämpfung von leptinotarsa
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
CN105555757A
(zh)
|
2013-07-23 |
2016-05-04 |
普洛体维生物治疗公司 |
用于递送信使rna的组合物和方法
|
US9540642B2
(en)
|
2013-11-04 |
2017-01-10 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Compositions and methods for controlling arthropod parasite and pest infestations
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
AU2015206585A1
(en)
|
2014-01-15 |
2016-07-21 |
Monsanto Technology Llc |
Methods and compositions for weed control using EPSPS polynucleotides
|
EP3420809A1
(de)
|
2014-04-01 |
2019-01-02 |
Monsanto Technology LLC |
Zusammensetzungen und verfahren zur bekämpfung von insektenbefall
|
WO2015200223A1
(en)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via rna interference
|
EP3161138A4
(de)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Verfahren und zusammensetzungen zur zuführung von nukleinsäuren an pflanzenzellen und regulierung der genexpression
|
WO2016018887A1
(en)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
AU2015328012A1
(en)
|
2014-10-02 |
2017-05-11 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing Hepatitis B virus gene expression
|
US10968449B2
(en)
|
2015-01-22 |
2021-04-06 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
UY36703A
(es)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
Composiciones y métodos para la administración de un polinucleótido en una planta
|
EP3302030A4
(de)
|
2015-06-03 |
2019-04-24 |
Monsanto Technology LLC |
Verfahren und zusammensetzungen zum einführen von nukleinsäuren in pflanzen
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
EP3329003A2
(de)
|
2015-07-29 |
2018-06-06 |
Arbutus Biopharma Corporation |
Zusammensetzungen und verfahren zur ausschaltung einer hepatitis-b-virus-genexpression
|
EP3478838A1
(de)
|
2016-06-30 |
2019-05-08 |
Arbutus Biopharma Corporation |
Zusammensetzungen und verfahren zur abgabe von boten-rna
|
WO2019118806A1
(en)
|
2017-12-14 |
2019-06-20 |
Solid Biosciences Inc. |
Non-viral production and delivery of genes
|
CN112841027B
(zh)
*
|
2021-03-08 |
2022-06-28 |
内蒙古民族大学 |
一种利用聚乙烯亚胺诱导玉米无融合生殖的育种方法及应用
|
WO2023018990A2
(en)
|
2021-08-12 |
2023-02-16 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
WO2023144792A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
WO2023215481A1
(en)
|
2022-05-05 |
2023-11-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
INTERFERING RNA THERAPY FOR PLN-R14del CARDIOMYOPATHY
|
WO2024031051A1
(en)
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|